Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA
Your view on DGWPF
Overview
What the company does, where it operates, and who runs it.
About Drägerwerk AG & Co. KGaA
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Stefan A. Drager
- Headquarters
- Moislinger Allee 53-55, Lübeck, DE
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Stefan A. Drager
- Headquarters
- Moislinger Allee 53-55, Lübeck, DE
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.
It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection.
The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services.
Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices.
In addition, the company offers various training and services, as well as fire training facilities for firefighters. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Drägerwerk AG & Co. KGaA, and the rating behind it. DGWPF last traded at $72.00, 12.2× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Drägerwerk AG & Co. KGaA. Starting points for Drägerwerk AG & Co. KGaA: P/E 12.2, EPS $9.13, beta 0.71 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Drägerwerk AG & Co. KGaA. Drägerwerk AG & Co. KGaA does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Drägerwerk AG & Co. KGaA. Trailing twelve-month EPS for Drägerwerk AG & Co. KGaA stands at $9.13. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Drägerwerk AG & Co. KGaA. Drägerwerk AG & Co. KGaA has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Drägerwerk AG & Co. KGaA valued side by side against its closest peers. Drägerwerk AG & Co. KGaA is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Drägerwerk AG & Co. KGaA, and how their positions are changing. At a $1.35B market value, institutional positions materially move Drägerwerk AG & Co. KGaA's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Drägerwerk AG & Co. KGaA executives and directors. Shares of Drägerwerk AG & Co. KGaA have traded between $45.05 and $72.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Drägerwerk AG & Co. KGaA. Drägerwerk AG & Co. KGaA is a $1.35B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Drägerwerk AG & Co. KGaA. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Drägerwerk AG & Co. KGaA. Coverage tracks Drägerwerk AG & Co. KGaA within Medical - Devices (Healthcare). Press releases and market coverage, newest first.